TNDMTANDEM DIABETES CARE INC

Nasdaq tandemdiabetes.com


$ 51.42 $ 2.07 (4.2 %)    

Wednesday, 22-May-2024 15:59:56 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 51.39
$ 51.33
$ 0.00 x 0
$ 0.00 x 0
$ 50.53 - $ 52.31
$ 13.82 - $ 52.51
2,053,182
na
3.36B
$ 1.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 04-30-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-30-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-27-2017 06-30-2017 10-Q
29 04-27-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-28-2016 03-31-2016 10-Q
34 02-24-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 07-31-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 lake-street-maintains-buy-on-tandem-diabetes-care-raises-price-target-to-75

Lake Street analyst Brooks O'Neil maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target fr...

 citigroup-upgrades-tandem-diabetes-care-to-buy-raises-price-target-to-57

Citigroup analyst Joanne Wuensch upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Neutral to Buy and raises the price target...

 stifel-maintains-buy-on-tandem-diabetes-care-raises-price-target-to-55

Stifel analyst Mathew Blackman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and raises the price target from $45 ...

 meme-stocks-gamestop-amc-fade-in-interest-after-roaring-kitty-exit-heres-what-wallstreetbets-is-eyeing-next

Retail traders could be shifting away from meme stocks to several other stocks seeing strong interest on WallSteetBets.

Core News & Articles

NVDAAIHIMSTSLADJTGMEPANWTNDMBBQQQData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

Core News & Articles

-Reuters 

 barclays-maintains-overweight-on-tandem-diabetes-care-raises-price-target-to-55

Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price target from...

 wells-fargo-maintains-overweight-on-tandem-diabetes-care-raises-price-target-to-50

Wells Fargo analyst Larry Biegelsen maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price targ...

 piper-sandler-reiterates-overweight-on-tandem-diabetes-care-raises-price-target-to-50

Piper Sandler analyst Matt O'Brien reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and raises the price ...

 wall-street-looks-to-feed-off-apples-post-earnings-power-but-key-jobs-data-may-upset-the-cart-analyst-says-a-lot-of-these-clouds-will-lift-if-this-happens

Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evi...

 baird-maintains-neutral-on-tandem-diabetes-care-raises-price-target-to-36

Baird analyst Jeff Johnson maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target from $28 ...

 tandem-diabetes-care-q1-2024-adj-eps-065-beats-076-estimate-sales-19280m-beat-17402m-estimate

Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION